SANGAMO BIOSCIENCE SGMO (NASDAQ)

$ 9.93
15:29
Change: -0.05 (-0.50%)
Volume: 138,510

Avg. Volume: 253126
P/E Ratio: 0
EPS (Annual): -0.66
Profit Margin:
Dividend & Yield(Annual): 0%
Shares Outstanding: 40,810
Institutional Shareholders: 60.69%
Last: 9.93
Change: -0.05 (-0.50%)
Prev. Close: 9.98
Open: 9.88
Day's Range: 9.73 - 10.03
52wk Range: 8.50 - 19.82
Market Value: 428,150
Beta: 2.31
12-month EPS Change: 1.54%
Total Return Last 12 Months: -11.84%
Total Return Last 3 Years: +53.27%
Total Return Last 5 Years: +273.78%
5-Year Revenue Growth Rate: 109.49%
5-Year Dividend Growth Rate: 0.00%
5-Year EPS Growth Rate: -52.46%


Headlines on SGMO

Movers roundup: Sangamo, Gen-Probe

Among the stock activity stories for Wednesday, July 9, from AP Financial News: Top stories:READ MORE
Jul 09, 2008 6:18PM
Keywords: SGMO, GPRO

Sangamo BioSciences shares gain on Roche deal

(NEW YORK)Shares of Sangamo BioSciences Inc. jumped Wednesday after the developer of genetic-based therapies said it signed a licensing deal with pharmaceuticals giant Roche.READ MORE
Jul 09, 2008 5:46PM
Keywords: SGMO, SIAL

Movers roundup: Cleveland-Cliffs, Sangamo BioSci

Among the stock activity stories for Wednesday, July 9, from AP Financial News: NEW YORK (AP)--Shares of Cleveland-Cliffs Inc. soared on Wednesday after the iron and coal miner rai...READ MORE
Jul 09, 2008 2:20PM
Keywords: SGMO, CACH

Sangamo technology shows promise in treating HIV

(RICHMOND, Calif.)Sangamo BioSciences Inc., which develops genetic-based therapies, said Monday data shows the company's technology can make certain cells in the immune system resistant to the H...READ MORE
Jun 30, 2008 9:23AM
Keywords: SGMO

Analysts: Sangamo's Dow deal could be key driver

(NEW YORK)Dow AgroSciences' move to license genetic-based therapies from Sangamo Biosciences Inc. could mean a large infusion of cash with little loss of product rights for the biotechno...READ MORE
Jun 19, 2008 3:35PM
Keywords: DOW, SGMO

Sangamo licenses gene technology for crops to Dow

(SAN DIEGO)Sangamo BioSciences Inc., which develops genetic-based therapies, said Thursday Dow AgroSciences exercised an option to license technology from Sangamo that turns genes on or off.READ MORE
Jun 19, 2008 8:44AM
Keywords: SGMO, DOW

Sangamo shares drop on plans to expand study

(NEW YORK)Shares of Sangamo BioSciences Inc. plunged Friday after the company said it will double the size of a midstage study and increase dosing for its nerve-disorder drug candidate, rais...READ MORE
Jun 06, 2008 4:53PM
Keywords: SGMO
RSS Page | Sign up for Google Alerts


Data Provided By Barchart.com
advertisement

Top Competitors

AMGEN +40.60 63.57
GILEAD SCIENCES +40.80 54.62
BIOGEN IDEC INC -5.30 54.10
GENENTECH INC +44.80 97.99
CELGENE CP +26.60 72.34